Home Duke University Press
 QUICK SEARCH:   [advanced]


     
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents


First published on February 26, 2008
This version was published on April 1, 2008
Neuro Oncol 2008 10(2):139-152; DOI:10.1215/15228517-2007-051
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
10/2/139    most recent
15228517-2007-051v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fu, Y.-S.
Right arrow Articles by Wang, J.-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Duke University Press

Basic and Translational Investigations

Tetramethylpyrazine inhibits activities of glioma cells and glutamate neuro-excitotoxicity: Potential therapeutic application for treatment of gliomas

Yu-Show Fu, Yen-Yang Lin, Shih-Chich Chou, Tung-Hu Tsai, Lung-Sen Kao, Shao-Yun Hsu, Fu-Chou Cheng, Yang-Hsin Shih, Henrich Cheng, Yu-Yi Fu and Jia-Yi Wang

Department of Anatomy (Y.-S.F.), Department of Pharmacology (H.C.); Institute of Anatomy and Cell Biology (Y.-Y.L., S.-C.C., S.-Y.H.), and Institute of Traditional Medicine (T.-H.T.), School of Medicine, National Yang-Ming University, Taipei, Taiwan; Faculty of Life Sciences, School of Life Sciences, National Yang-Ming University, Taipei, Taiwan (L.-S.K.); Department of Education and Research, Taipei City Hospital, Taipei, Taiwan (Y.-S.F., T.-H.T.); Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan (F.-C.C.); Department of Neurosurgery, Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan (Y.-H.S.); School of Medicine, Taipei Medical University, Taipei, Taiwan (Y.-H.S.); Neural Regeneration Laboratory and Center for Neural Regeneration, Department of Neurosurgery, Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan (H.C.); Department of Automation Engineering, Nan Kai Institute of Technology, Nantou, Taiwan (Y.-Y.F.); and Department of Physiology, National Defense University, Taipei, Taiwan (J.-Y.W.)

Address correspondence to Yu-Show Fu, Department of Anatomy, School of Medicine, National Yang-Ming University, 155 Sec. 2, Li-Nung Street, Taipei, Taiwan, 112 (ysfu{at}ym.edu.tw).

We tested the herbal extract 2,3,5,6-tetramethylpyrazine (TMP) for possible therapeutic efficacy against a glioma cell line and against gliomas transplanted into rat brains. In the cultured glioma cells, 50 µM TMP significantly inhibited glutamate-induced increase in intracellular calcium. Significant cell damage (30%) and proliferation suppression (10%), however, occurred only at higher concentrations (200-400 µM). Gliomaneuronal co-culturing resulted in significant neuronal damage and higher proliferation of the glioma cells (140%) compared with single cultures. Low concentrations of TMP (≤200 µM) attenuated the neuronal damage, suppressed glioma migration, and decreased glioma proliferation in the neuronal-glioma co-culture. Gliomas transplanted into the frontal cortical area exhibited high proliferation, with untreated rats dying 10-23 days later. TMP treatment inhibited tumor growth and significantly extended survival time. The results indicate that TMP can suppress glioma activity, including growth, and protect neurons against glioma-induced excitotoxicity, suggesting that TMP may have therapeutic potential in the treatment of malignant gliomas.

Key Words: calcium • excitotoxicity • glioblastoma multiforme • tetramethylpyrazine


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
JCOHome page
S. A. Grossman, X. Ye, M. Chamberlain, T. Mikkelsen, T. Batchelor, S. Desideri, S. Piantadosi, J. Fisher, and H. A. Fine
Talampanel With Standard Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma: A Multicenter Phase II Trial
J. Clin. Oncol., September 1, 2009; 27(25): 4155 - 4161.
[Abstract] [Full Text] [PDF]


Home page
Neuro Oncol DukeHome page
R. Roesler, N. Schroder, and G. Schwartsmann
LETTER TO THE EDITOR
Neuro-oncol, January 1, 2009; 11(2): 236 - 237.
[Full Text] [PDF]




  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents


Copyright 2008 by Society for Neuro-Oncology